Clinical characteristics of coronavirus disease 2019 patients with hepatitis B virus super-infection
2024

COVID-19 Patients with Hepatitis B Super-Infection

Sample size: 249 publication Evidence: moderate

Author Information

Author(s): Yu Shan, Song Cunzheng

Primary Institution: Shanghai Jiao Tong University School of Medicine, Ren Ji Hospital

Hypothesis

Does HBV super-infection worsen liver function and disease prognosis in COVID-19 patients?

Conclusion

HBV super-infection slightly affects liver function but does not worsen COVID-19 outcomes.

Supporting Evidence

  • 37 out of 249 COVID-19 patients were super-infected with HBV.
  • Patients with HBV super-infection had lower white blood cell, neutrophil, and platelet counts.
  • Total bilirubin levels were significantly higher in the HBV super-infected group.

Takeaway

This study looked at COVID-19 patients who also had hepatitis B and found that having both didn't make their COVID-19 worse, but it did affect their liver a little.

Methodology

Retrospective analysis of clinical characteristics, laboratory data, and treatment outcomes of COVID-19 patients with and without HBV super-infection.

Potential Biases

Potential biases due to retrospective design and selection criteria.

Limitations

The study is limited to a single center and may not be generalizable to all populations.

Participant Demographics

Patients aged 18 to 80 years, with 55.8% men.

Statistical Information

P-Value

0.022

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1590/S1678-9946202466074

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication